ChristopherTDennyMD
Pediatric Hematology & Oncology • Los Angeles, CAProfessor, Pediatrics, UCLA School of Medicine
Are you Dr. Denny?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10833 Le Conte Ave
12441 MDCC
Los Angeles, CA 90095Phone+1 310-206-3952Fax+1 310-206-0209
Summary
- Dr. Christopher Denny, MD is a pediatric hematologist/oncologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is affiliated with Mattel Childrens Hospital University of California Los Angeles and Ronald Reagan UCLA Medical Center.
Education & Training
National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1983 - 1986
Children's National HospitalResidency, Pediatrics, 1980 - 1983
Perelman School of Medicine at the University of PennsylvaniaClass of 1980
Certifications & Licensure
CA State Medical License 1987 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
- American Board of Preventive Medicine Clinical Informatics
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1998
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 21 citationsLeveraging genomic diversity for discovery in an electronic health record linked biobank: the UCLA ATLAS Community Health Initiative.Ruth Johnson, Yi Ding, Vidhya Venkateswaran, Arjun Bhattacharya, Kristin Boulier
Genome Medicine. 2022-09-09 - 398 citationsThe Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.William A. May, Stephen L. Lessnick, Benjamin S. Braun, Michael Klemsz, Brian C. Lewis
Molecular and Cellular Biology. 1993-12-01 - 559 citationsA second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS–family transcription factor, ERGPoul H. Sorensen, Stephen L. Lessnick, Dolores Lopez-Terrada, Xian F. Liu, Timothy J. Triche
Nature Genetics. 1994-02-01
Grant Support
- Defining Mechanisms Of Tumorigenesis By EWS/ETS FusionsNational Cancer Institute2000–2010
- Core--Data Management And BiostatisticsNational Institute Of Allergy And Infectious Diseases2007–2008
- Core C - Data Management &BiostatisticsNational Institute Of Allergy And Infectious Diseases2006
- Data Management And BiostatisticsNational Institute Of Allergy And Infectious Diseases2004–2006
- Molecular Mechanisms Of Cellular Transformation By The EWS/FLI Fusion GeneNational Cancer Institute1995–2002
- Assessing Gene Expression In Pediatric TumorsNational Cancer Institute1998–1999
- Pre-Clinical Model For Gene Therapy Of X-Linked AgammaglobulinemiaNational Cancer Institute1994–1998
- Molecular Study Of Ewing Sarcoma T 11-22 TranslocationNational Cancer Institute1989–1993
